Avid Bioservices Inc (CDMO)

[pphmtoolong]

Peregrine management. Stop needlessly diluting our ownership. If bavi-immunotherapy is as good as you think, find a partner to share the cost. If you can't find a partner in six months, forget about Bavi like you forgot about Cotara and the other projects that just didn't work.

There is no shame in becoming a profitable manufacturer of biologicals. There is however a possible return on shareholders investments.

Isn't it your fiduciary responsibility to make prudent use of our resources. If you don't, don't you deserve to spend your next ten years answering for it in court.

Not bitter about Bavi. It looked promising in the lab, but hasn't shown much promise in the clinic.

To repeat, if bavi-immunotherapy is worth risking shareholder funds, why wouldn't a BP partner be motivated to participate?

GLTA, Paul